Planet Innovation is partnering with Melbourne-based start-up Scinogy to manufacture a revolutionary new cell processing system that is being commercialized by global biotechnology company Thermo Fisher Scientific.
The AusBiotech National Conference, held in sunny Brisbane, brought together national and international leaders from across the life sciences industry. I took the opportunity to pop into a number of sessions on the growing AI and digital health sectors.
Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.
Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.
Despite 30 years of IVF practice the process of freezing human embryos, known as vitrification, has remained extremely manual and susceptible to errors and inconsistencies by embryologists. In 2009, Genea Biomedx teamed up with Planet Innovation to solve this challenge by automating IVF vitrification and finally making the process consistent and standardised for labs around the world.